Search Clinical Trials
| Sponsor Condition of Interest |
|---|
|
Efficacy of SynEx Wound Rinse in Civilian Surrogates of Combat Injury Wounds
Synedgen, Inc.
Wound Heal
The purpose of this interventional study is to compare SynEx Wound Cleanser with the
current routine care (Saline) in traumatic wounds. Participants with gunshot, penetrating
or burn wounds who participate will be asked to attend up to four study visits, use the
assigned wound cleanser and complete1 expand
The purpose of this interventional study is to compare SynEx Wound Cleanser with the current routine care (Saline) in traumatic wounds. Participants with gunshot, penetrating or burn wounds who participate will be asked to attend up to four study visits, use the assigned wound cleanser and complete brief surveys about their healing and well-being related to the wound healing. Type: Interventional Start Date: Apr 2023 |
|
International CDKL5 Clinical Research Network
University of Colorado, Denver
CDKL5
CDKL5 Deficiency Disorder
CDD
Pathogenic variants in the Cyclin-dependent kinase like 5 (CDKL5) gene cause CDKL5
deficiency disorder (CDD, MIM 300672, 105830), a severe developmental and epileptic
encephalopathy associated with cognitive and motor impairments and cortical visual
impairment. While capability for disease modifyin1 expand
Pathogenic variants in the Cyclin-dependent kinase like 5 (CDKL5) gene cause CDKL5 deficiency disorder (CDD, MIM 300672, 105830), a severe developmental and epileptic encephalopathy associated with cognitive and motor impairments and cortical visual impairment. While capability for disease modifying therapies is accelerating, there is a critical barrier for clinical trial readiness that may result in failure of these therapies, not due to lack of efficacy but due to lack of validated outcome measures and biomarkers. The measures and biomarkers validated here will be adaptable to other developmental and epileptic encephalopathies. Type: Observational Start Date: Feb 2021 |